Marshall Wace Asia
RDY icon

Marshall Wace Asia’s Dr. Reddy's Laboratories RDY Stock Holding History

Marshall Wace Asia’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-58,830
Closed -$477K – 175
2019
Q4 		$477K Sell
58,830
-86,905
-60% -$686K 0.01% 96
2019
Q3 		$1.1M Buy
+145,735
New +$1.08M 0.03% 90

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Aperio Group
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Parametric Portfolio Associates
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Marshall Wace Asia's RDY Position: Q1 2020 in Review

Marshall Wace Asia sold out of Dr. Reddy's Laboratories (RDY) in Q1 2020, closing a stake of 58,830 shares — an estimated $477K sold.

Marshall Wace Asia first reported a position in RDY in Q3 2019 and held it in 2 quarters. The position peaked at $1.1M in Q3 2019. 148 funds tracked by Wall St. Rank hold RDY as of Q1 2020.

  • Marshall Wace Asia reported no remaining Dr. Reddy's Laboratories position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace Asia sold 58,830 Dr. Reddy's Laboratories shares in Q1 2020, an estimated $477K.
  • Marshall Wace Asia first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 2 quarters.
  • Marshall Wace Asia's Dr. Reddy's Laboratories position peaked at $1.1M in Q3 2019.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2020.

Based on Marshall Wace Asia's 13F filing for Q1 2020, filed 15 May 2020.